Richard Nowak, MD, MS
Associate Professor of NeurologyCards
About
Research
Overview
https://medicine.yale.edu/neurology/divisions/neuromuscular/nmresearch.aspx
Medical Subject Headings (MeSH)
Clinical Care
Overview
Richard Nowak, MD, MS, is the director of the Yale Myasthenia Gravis Clinic, where he treats patients with the chronic, autoimmune condition that causes muscles to tire and weaken easily. He provides personalized treatment strategies for patients suffering from myasthenia gravis and other autoimmune neuromuscular conditions.
In addition, Dr. Nowak works with the Yale Medicine Neuromuscular Medicine Program, which is supported by the Muscular Dystrophy Association (MDA), and is a designated MDA-ALS clinic. The program provides comprehensive diagnostic evaluation, consultation and management for a range of neuromuscular disorders.
An associate professor of neurology at Yale School of Medicine, Dr. Nowak is also a busy researcher who directs the Program in Clinical and Translational Neuromuscular Research at Yale, where his goal is to improve the understanding of autoimmune neuromuscular disorders, identify new drug targets and explore new therapies. In 2013, he was awarded a $4.8 million grant to conduct the first clinical trial for myasthenia gravis sponsored by the National Institutes of Health.
Clinical Specialties
Fact Sheets
Stiff Person Syndrome (SPS)
Learn More on Yale MedicineMyasthenia Gravis
Learn More on Yale MedicineGuillain-Barré Syndrome
Learn More on Yale MedicineAmyloidosis
Learn More on Yale Medicine
Board Certifications
Neuromuscular Medicine
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2021
Yale Medicine News
Links & Media
News
- November 17, 2023Source: Yale Medicine
Myasthenia Gravis: New Drugs and a Road to Individualized Treatment
- November 06, 2023Source: Medpage Today
What's on the Horizon for Myasthenia Gravis – Cell-based therapies, broader B-cell targeting, and immune tolerance are all in the works
- November 03, 2023Source: Medpage Today
A Changing Treatment Landscape in Myasthenia Gravis – A spate of new approvals set off a "revolution" in management
- April 12, 2023
Nowak Receives Impact Award